HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Arca Selected Research

Therapeutics

3/2011Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Arca Research Topics

Disease

1Neoplasms (Cancer)
03/2011
1Prostatic Neoplasms (Prostate Cancer)
03/2011

Drug/Important Bio-Agent (IBA)

1gallocatechol (epigallocatechin)IBA
03/2011
1AntigensIBA
03/2011
1PhytochemicalsIBA
03/2011

Therapy/Procedure

1Therapeutics
03/2011
1Chemoprevention
03/2011